Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

Press releases published on July 17, 2026

31 minutes ago

Arch Biopartners Engages Private Laboratory to Accelerate IL-32 Chronic Kidney Disease Program

Indeterminate GlobeNewswire

an hour ago

Glucotrack, Inc. and Lōkahi Therapeutics™ Announce Strategic Financing Support from E.F. Hutton & Co. in Connection with Their Recently Completed Business Combination and Future Capital Markets Initiatives

Indeterminate GlobeNewswire

an hour ago

Enovis to Host Second Quarter 2026 Results Conference Call on August 6th

Indeterminate GlobeNewswire

an hour ago

Damora Announces Redomestication from Delaware to Cayman Islands

Indeterminate GlobeNewswire

an hour ago

Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations

Indeterminate GlobeNewswire

an hour ago

SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology

Indeterminate GlobeNewswire

an hour ago

Clearmind Medicine Commends Federal Momentum in Advancing Psychedelic-Based Therapies for Mental Health and Addiction

Indeterminate GlobeNewswire

an hour ago

Artiva Biotherapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

2 hours ago

Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026

Indeterminate GlobeNewswire

2 hours ago

BeechBand Founder's Personal Search for Relief Led to Wearable Now Reaching Customers in Six Countries

Indeterminate GlobeNewswire

2 hours ago

BrewDog and Tilray Brands Unlock £1 Million Bar Tab for Football Fans Across England, Scotland and Ireland

Indeterminate GlobeNewswire

2 hours ago

Kalaris Therapeutics Reports Positive TH103 Phase 1a SAD Results from Expanded Neovascular AMD Cohorts

Indeterminate GlobeNewswire

5 hours ago

Mission Therapeutics strikes deal worth up to $292 million for Dimerix Ltd to develop Acute Kidney Injury asset MTX652, sharpens focus on its CNS pipeline

Indeterminate GlobeNewswire

7 hours ago

European Commission approves JASCAYD®, bringing well-tolerated, novel oral treatment for IPF and PPF to the EU

Indeterminate GlobeNewswire

10 hours ago

Enjoin Reports 923% Average ROI Delivered in Q1 2026

Indeterminate GlobeNewswire